![Jeffrey Fryer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Fryer
Plus aucun poste en cours
Profil
Mr. Jeffrey M.
Fryer was previously employed as a Chief Financial Officer & Treasurer by Rallybio Corp., a Co-Founder by Rallybio LLC, and a Chief Tax Officer & Vice President by Alexion Pharmaceuticals, Inc. He received his undergraduate degree from Bryant University and a graduate degree from the University of Hartford.
Anciens postes connus de Jeffrey Fryer
| Sociétés | Poste | Fin |
|---|---|---|
| RALLYBIO CORPORATION | Fondateur | 01/02/2023 |
| ALEXION PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/04/2017 |
Rallybio LLC
 Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotech company that delivers groundbreaking therapies | Fondateur | - |
Formation de Jeffrey Fryer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
74
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
University of Hartford
 University of Hartford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bryant University
 Bryant University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rallybio LLC
Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotech company that delivers groundbreaking therapies | Commercial Services |
Rallybio Corp.
 Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
